GEODE CAPITAL MANAGEMENT, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$3,220,000
+56.4%
624,146
+9.1%
0.00%0.0%
Q1 2019$2,059,000
-68.1%
572,084
-45.7%
0.00%0.0%
Q4 2018$6,452,000
+154.4%
1,052,658
+142.3%
0.00%0.0%
Q3 2018$2,536,000
+48.1%
434,361
+7.8%
0.00%0.0%
Q2 2018$1,712,000
+22.5%
403,049
+27.2%
0.00%
Q1 2018$1,397,000
-15.3%
316,935
+1.1%
0.00%
-100.0%
Q4 2017$1,649,000
-7.8%
313,626
+7.4%
0.00%0.0%
Q3 2017$1,789,000
-13.7%
291,972
+1.9%
0.00%0.0%
Q2 2017$2,072,000
+60.7%
286,599
+17.8%
0.00%0.0%
Q1 2017$1,289,000
-22.9%
243,352
+4.5%
0.00%0.0%
Q4 2016$1,672,000
-13.5%
232,887
+12.7%
0.00%0.0%
Q3 2016$1,933,000
+61.8%
206,555
+9.2%
0.00%0.0%
Q2 2016$1,195,000
+17.7%
189,185
+2.9%
0.00%0.0%
Q1 2016$1,015,000
+0.4%
183,881
+1.4%
0.00%0.0%
Q4 2015$1,011,000
-33.5%
181,331
+0.9%
0.00%0.0%
Q3 2015$1,520,000
-42.8%
179,780
+2.3%
0.00%
-50.0%
Q2 2015$2,656,000
-5.0%
175,717
+0.6%
0.00%0.0%
Q1 2015$2,797,000
-8.7%
174,720
+1.6%
0.00%0.0%
Q4 2014$3,065,000
+148.6%
172,023
+40.1%
0.00%
+100.0%
Q3 2014$1,233,000
-26.0%
122,813
+14.9%
0.00%0.0%
Q2 2014$1,667,000
-4.9%
106,852
+13.2%
0.00%0.0%
Q1 2014$1,752,000
+168.3%
94,416
+176.2%
0.00%
Q4 2013$653,000
+19.4%
34,190
+2.2%
0.00%
Q3 2013$547,00033,4580.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders